What is the treatment for measles?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 15, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment for Measles

The treatment for measles is primarily supportive care, with vitamin A supplementation being essential for all children with clinical measles (200,000 IU for children over 12 months; 100,000 IU for younger children), and antibiotics should be administered for measles complications such as pneumonia and other bacterial infections. 1

Supportive Care

Supportive care forms the backbone of measles treatment and includes:

  • Adequate hydration and nutrition
  • Antipyretics for fever management
  • Rest
  • Monitoring for complications

Vitamin A Supplementation

Vitamin A supplementation is a critical component of measles treatment:

  • For children ≥12 months: 200,000 IU orally on day 1
  • For children <12 months: 100,000 IU orally on day 1
  • For complicated measles (pneumonia, otitis, croup, diarrhea with dehydration, or neurological problems): a second dose on day 2
  • This should be repeated every 3 months as part of routine vitamin A supplementation 1

Management of Complications

Measles complications occur in 10-40% of patients and require specific interventions:

  • Diarrhea: Oral rehydration therapy (ORT)
  • Acute lower respiratory infections: Appropriate antibiotics
  • Otitis media: Antibiotics as indicated
  • Neurological complications: Supportive care and close monitoring

For patients with vitamin A deficiency symptoms (xerosis, Bitot's spots, keratomalacia, or corneal ulceration), follow this treatment schedule:

  • 200,000 IU oral vitamin A on day 1
  • 200,000 IU oral vitamin A on day 2
  • 200,000 IU oral vitamin A 1-4 weeks later
  • Children <12 months receive half doses 1

Special Populations

Immunocompromised Patients

For immunocompromised patients exposed to measles:

  • Immune globulin (IG) should be administered as soon as possible after exposure
  • Dosage: 0.5 mL/kg of body weight intramuscularly (maximum dose = 15 mL)
  • This corresponds to approximately 82.5 mg/kg of IgG protein 1

Pregnant Women

Pregnant women with measles require close monitoring due to increased risks of:

  • Premature labor
  • Spontaneous abortion
  • Low birth weight infants 1

Post-Exposure Prophylaxis

For susceptible individuals exposed to measles:

  • Measles vaccine may provide protection or modify disease severity if administered within 3 days of exposure 1
  • For those with contraindications to vaccination, IG (0.25 mL/kg, maximum 15 mL) should be given as soon as possible after exposure 1

Nutritional Support

All children with measles should:

  • Have their nutritional status monitored
  • Be enrolled in a feeding program if undernourished 1

Infection Control Measures

To prevent transmission:

  • Report suspected cases to local health departments immediately
  • In healthcare settings, use airborne precautions including N-95 masks and isolation in airborne infection isolation rooms 2
  • Isolation in emergency camp settings is not indicated 1

Common Pitfalls to Avoid

  • Delaying vitamin A supplementation - this should be given promptly
  • Failing to monitor for and treat complications
  • Not reporting cases to public health authorities
  • Underestimating the severity of measles - it can cause significant morbidity and mortality
  • Withholding vaccination during outbreaks - immunization efforts should be accelerated during outbreaks 1

Remember that undernutrition, fever, respiratory tract infection, and diarrhea are NOT contraindications for measles vaccination. In fact, undernutrition should be considered a strong indication for vaccination to prevent severe disease 1.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

An Update and Review of Measles for Emergency Physicians.

The Journal of emergency medicine, 2020

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.